Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Several physicians, nurses and allied health professionals from the Peter Munk Cardiac Centre, along with their colleagues from across Canada, will exchange knowledge and share information this weekend at the Canadian Cardiovascular Congress (CCC), the largest annual meeting of its kind in the country.
Bringing together some of the world's leading medical minds in the field of cardiac and vascular disease, the three-day event beginning Saturday at the Metro Toronto Convention Centre is co-hosted by the Canadian Cardiovascular Society (CCS) and the Heart and Stroke Foundation.
Dr. Vivek Rao, Division Chief, Cardiovascular Surgery at PMCC, will present science data evaluating novel techniques to improve organ preservation for transplant. He describes the specific impact of the knowledge dissemination from past Congress gatherings on his area of expertise.
"We've adopted better ICU care algorithms and reviewed our approach to both heart transplants and ventricular assist devices (VADs)," Dr. Rao says. "We continue to strive to increase our use of arterial grafts for coronary artery bypass grafting and to use minimally-invasive incisions for valve surgery."
The Canadian Cardiovascular Society:
Dr. Danna Spears, a cardiologist at PMCC focused on the electrical functioning of the heart, will discuss innovation that is enabling the "zero-fluoroscopy approach." Fluoroscopy is a type of imaging technique involving x-rays.
"This is a novel approach to electrophysiology (EP) procedures that uses a complex mapping system rather than x-ray to complete diagnostic or therapeutic cases," says Dr. Spears. "This is an important aspect of the arrhythmia component of the U of T pregnancy and heart disease program, allowing us to offer women an interventional option when necessary, without the risk of radiation exposure to themselves or their fetus."
Vascular surgeon, Dr. Thomas Forbes, will share insight on interventions for thoracic aortic disease.
"The position statement offers evidence-based recommendations regarding the care of patients with thoracic aortic disease (dissections, aneurysms etc.)," says Dr. Forbes. He adds such recommendations provide, "certainty from the physician standpoint regarding indications for surgical intervention and what intervention is best, removes ambiguity around care of these complex problems which would directly lead to better patient care and improved outcomes after such high risk operations."
Cardiologist, Dr. Dinesh Thavendiranathan, recently-named Director of the Ted Rogers Program in Cardiotoxicity Prevention, will discuss more robust methods to manage patients receiving potentially cardiotoxic chemotherapy, and better understand the mechanisms of cardiotoxicity.